Российский кардиологический журнал (Dec 2020)

Resolution of the online meeting of Russian experts on the EMPEROR-REDUCED trial

  • G. P. Arutyunov,
  • A. G. Arutyunov,
  • E. I. Tarlovskaya,
  • A. S. Ametov,
  • N. G. Vinogradova,
  • A. A. Garganeeva,
  • M. G. Glezer,
  • I. V. Zhirov,
  • M. V. Ilyin,
  • N. A. Koziolova,
  • A. O. Konradi,
  • A. Yu. Lebedeva,
  • Yu. M. Lopatin,
  • S. V. Nedogoda,
  • V. V. Salukhov,
  • M. Yu. Sitnikova,
  • S. N. Tereshchenko,
  • S. N. Tolstov,
  • Yu. Sh. Khalimov,
  • N. R. Khasanov,
  • A. I. Chesnikova,
  • V. Giga,
  • M. Paсker

DOI
https://doi.org/10.15829/29/1560-4071-2020-4167
Journal volume & issue
Vol. 25, no. 11

Abstract

Read online

At the online meeting held on September 3, 2020, the results of the international multicenter trial EMPEROR-REDUCED were considered. Number of proposals and recommendations for the further study of cardiovascular and renal effects of empagliflozin and its practical use in heart failure patients were agreed.

Keywords